Jay Olson
Stock Analyst at Oppenheimer
Total Price Targets
39
Stocks Covered
20
Sectors
Healthcare
Most Recent
Mar 13, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Jay Olson
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | $140.00 | $86.71 | +61.5% | 2 | Mar 13, 2026 |
| BIIB | Biogen Inc. | $225.00 | $186.69 | +20.5% | 4 | Jan 30, 2026 |
| RVMD | Revolution Medicines, Inc. | $150.00 | $140.52 | +6.7% | 4 | Jan 27, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $220.00 | $204.09 | +7.8% | 1 | Dec 31, 2025 |
| PRAX | Praxis Precision Medicines, Inc. | $750.00 | $330.59 | +126.9% | 2 | Dec 15, 2025 |
| MDGL | Madrigal Pharmaceuticals, Inc. | $650.00 | $516.66 | +25.8% | 2 | Nov 20, 2025 |
| TERN | Terns Pharmaceuticals, Inc. | $24.00 | $52.94 | -54.7% | 2 | Nov 3, 2025 |
| IMRX | Immuneering Corporation | $30.00 | $5.39 | +456.6% | 1 | Sep 25, 2025 |
| VYGR | Voyager Therapeutics, Inc. | $18.00 | $3.75 | +379.4% | 1 | Nov 13, 2024 |
| NTLA | Intellia Therapeutics, Inc. | $60.00 | $13.20 | +354.5% | 1 | Nov 11, 2024 |
| CRSP | CRISPR Therapeutics AG | $95.00 | $51.72 | +83.7% | 2 | Nov 6, 2024 |
| INCY | Incyte Corporation | $82.00 | $96.41 | -14.9% | 4 | Oct 30, 2024 |
| NBIX | Neurocrine Biosciences, Inc. | $192.00 | $131.64 | +45.9% | 2 | Oct 22, 2024 |
| PRTA | Prothena Corporation plc | $62.00 | $10.86 | +470.9% | 1 | Aug 14, 2024 |
| SKYE | Skye Bioscience, Inc. | $21.00 | $0.83 | +2440.5% | 2 | Jun 10, 2024 |
| AMGN | Amgen Inc. | $380.00 | $328.69 | +15.6% | 3 | May 17, 2024 |
| VKTX | Viking Therapeutics, Inc. | $138.00 | $29.80 | +363.0% | 1 | Mar 26, 2024 |
| ACAD | ACADIA Pharmaceuticals Inc. | $19.00 | $21.95 | -13.5% | 2 | Mar 12, 2024 |
| MRK | Merck & Co., Inc. | $147.00 | $111.89 | +31.4% | 1 | Apr 12, 2023 |
| RLMD | Relmada Therapeutics, Inc. | $7.00 | $7.66 | -8.6% | 1 | Oct 13, 2022 |
Recent Activity
- Mar 13, 2026— Set$140.00price target onNKTR(Nektar Therapeutics)
- Jan 30, 2026— Set$225.00price target onBIIB(Biogen Inc.)
- Jan 27, 2026— Set$150.00price target onRVMD(Revolution Medicines, Inc.)
- Dec 31, 2025— Set$220.00price target onAXSM(Axsome Therapeutics, Inc.)
- Dec 16, 2025— Set$115.00price target onNKTR(Nektar Therapeutics)
- Dec 15, 2025— Set$750.00price target onPRAX(Praxis Precision Medicines, Inc.)
- Nov 20, 2025— Set$650.00price target onMDGL(Madrigal Pharmaceuticals, Inc.)
- Nov 3, 2025— Set$24.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Oct 10, 2025— Set$590.00price target onMDGL(Madrigal Pharmaceuticals, Inc.)
- Sep 25, 2025— Set$30.00price target onIMRX(Immuneering Corporation)
- Jun 2, 2025— Set$97.00price target onPRAX(Praxis Precision Medicines, Inc.)
- May 2, 2025— Set$205.00price target onBIIB(Biogen Inc.)
- Dec 3, 2024— Set$20.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Nov 13, 2024— Set$18.00price target onVYGR(Voyager Therapeutics, Inc.)
- Nov 11, 2024— Set$60.00price target onNTLA(Intellia Therapeutics, Inc.)
- Nov 6, 2024— Set$95.00price target onCRSP(CRISPR Therapeutics AG)
- Oct 31, 2024— Set$255.00price target onBIIB(Biogen Inc.)
- Oct 30, 2024— Set$82.00price target onINCY(Incyte Corporation)
- Oct 28, 2024— Set$60.00price target onRVMD(Revolution Medicines, Inc.)
- Oct 22, 2024— Set$192.00price target onNBIX(Neurocrine Biosciences, Inc.)
Frequently Asked Questions
Who is Jay Olson?
Jay Olson is a stock analyst at Oppenheimer covering 20 stocks primarily in Healthcare. They have issued 39 price targets since Nov 3, 2021.
What stocks does Jay Olson cover?
Jay Olson currently covers 20 stocks, including BIIB, RVMD, INCY, AMGN, NKTR.
What is Jay Olson's latest price target?
Jay Olson's most recent price target was $140.00 on NKTR (Nektar Therapeutics), set on Mar 13, 2026.
What is Jay Olson's highest price target?
Jay Olson's highest issued price target is $750.00 on PRAX, set on Dec 15, 2025.
More Analysts at Oppenheimer
Coverage based on publicly published price targets. Not investment advice.